Searchable abstracts of presentations at key conferences on calcified tissues
Bone Abstracts (2013) 1 OC6.5 | DOI: 10.1530/boneabs.01.OC6.5

ECTS2013 Oral Communications Mineralisation and energy metabolism (6 abstracts)

A protective role for FGF23 in local defence against disrupted arterial wall integrity?

Dongxing Zhu 1 , Neil Mackenzie 1 , Jose Luis Millan 2 , Colin Farquharson 1 & Vicky MacRae 1

1The Roslin Institute and Royal (Dick) School of Veterinary Studies, The University of Edinburgh, Easter Bush, Roslin, Midlothian EH25 9RG, Scotland, UK; 2Sanford Children’s Health Research Center, Sanford-Burnham Medical Research Institute, La Jolla, California 92037, USA.

Increasing interest is focusing on the role of the FGF-23/Klotho axis in mediating vascular calcification. However, the underpinning mechanisms have yet to be fully elucidated. Murine VSMCs were cultured in calcifying medium for a 21-day period. FGF-23 mRNA expression was significantly up-regulated by 7 days (1.63-fold; P<0.001), with a concomitant increase in protein expression. mRNA and protein expression of both FGFR1 and Klotho were confirmed. Increased FGF-23 and Klotho protein expression was also observed in the calcified media of Enpp1−/− mouse aortic tissue. Reduced calcium deposition was observed in calcifying VSMCs cultured with recombinant FGF-23 (10 ng/ml; 28.1% decrease; P<0.01). Calcifying VSMCs treated with PD173074, an FGFR1 inhibitor, showed significantly increased calcification (50 nM; 87.8% increase; P<0.001). FGF-23 exposure induced phosphorylation of ERK1/2. Treatment with FGF-23 in combination with PD98059, an ERK1/2 inhibitor, significantly increased VSMC calcification (10 μM; 41.3% increase; P<0.01). FGF-23 may represent a novel therapeutic strategy for inhibiting vascular calcification.

Volume 1

European Calcified Tissue Society Congress 2013

Lisbon, Portugal
18 May 2013 - 22 May 2013

European Calcified Tissue Society 

Browse other volumes

Article tools

My recent searches

No recent searches.